Our Dedicated Team
I believe the world is an abundant ocean of opportunity which is why I am an avid entrepreneur. I recognize possibilities and then leverage my resources to bring a vision to life. As a kid I liked taking things apart and putting them back together again, often adding inventive touches along the way. My early work in engineering, telecommunications, and consulting eventually parlayed into entrepreneurship that after 10 startups has culminated in more successes than failures. With a rich, eclectic background that includes engineering, biology, psychology, computer science, and marketing, I use design thinking that leverages continuously evolving platform technologies to connect people in unique ways. Having recognized the amazing potential in Plasma Directed Electron Beam™ technology, I am creating a team of talented, passionate individuals to bring exciting new products to the market that can make a difference.
Adrianne R. Blocklin, PMP
I am a certified Project Management Professional (PMP)® with more than a decade of technical and project management experience, leading multifunctional, global teams. With beginnings as a biochemist, I have conducted research in biochemistry, medicinal chemistry, organic chemistry, aerosol science, microbiology and surface chemistry. I have served as a subject matter expert in biological and chemical sensor development and testing, and more recently specialized in the development of Ion Mobility Spectrometry (IMS)-based narcotics and explosives trace detection technology. I also have experience leading policy, process and protocol development in safety, lab practice, manufacturing, quality control and regulatory compliance.
Dr. Joseph A. Bauer, Ph.D.
Chief Science Advisor
I earned my doctorate in chemistry from the University of Akron, was a cancer immunology fellow at the Cleveland Clinic’s Lerner Research Institute and also managed to pick up a degree in Business Administration from Walsh University along the way. I have more than 25 years of experience within fields of specialization including signal transduction pathways, apoptosis, cobalamin chemistry, molecular biology and the biochemistry of nitric oxide. I have received over $5M in grant support from the National Institutes of Health (NIH), the National Cancer Institute (NCI) and various other foundations for research pertaining to the synthesis and testing of nitric oxide-donor compounds. My work has resulted in three United States Patents and over twenty-five foreign patents. I have authored more than 100 abstracts and manuscripts, and currently serve as an academic editor for the scientific journal PLoS ONE.